摘要
目的调查新疆维吾尔自治区(新疆)部分包虫病流行地区患者药物治疗情况。方法2013年4—6月通过问卷形式对新疆4个包虫病医疗点(新疆医科大学第一附属医院、布克塞尔蒙古自治县、额敏县和裕民县)进行包虫病规范化药物治疗现况调查,以WHO包虫病药物治疗建议作为规范化治疗标准。结果共调查329例包虫病患者,其中行抗包虫药物治疗250例,规范化药物治疗占49.2%(162/329);未规范化药物治疗病例50.8%(167/329)。结论新疆部分包虫病地区患者临床药物治疗亟待规范,其综合陛防治应包括规范化诊断、手术、药物治疗以及随访的个体治疗。
Objective To understand the performance of echinococcosis chemotherapy in echinococcosis endemic areas in Xinjiang Uygur autonomous region (Xinjiang). Methods A questionnaire survey was conducted in the First Affiliated Hospital of Xinjiang Medical University, Hoboksar Mongolia autonomous county, Ermin and Yumin counties from April to June in 2013. Results A total of 329 echinococcosis patients were surveyed, and chemotherapy was provided according to WHO echinococcosis treatment recommendation, the standard treatment rate was and non-standardized medication was 49.2% (162/329) and 50.8% (167/329) , respectively. Conclusion It is necessary to standardize the chemotherapy of echinococcosis in some echinococcosis endemic areas in Xinjiang. The comprehensive prevention and treatment include standardized diagnosis, surgical treatment and chemotherapy as well as follow up for individualized treatment.
出处
《中华流行病学杂志》
CAS
CSCD
北大核心
2015年第9期1002-1004,共3页
Chinese Journal of Epidemiology
基金
中国博士后科学奖励基金(2014M552570xB)
国家自然科学基金(81260220)
国家临床重点专科地方病包虫病专项
关键词
包虫病
药物治疗
现况调查
Echinococcosis
Chemotherapy
Cross-sectional survey